Exercise program for Black breast cancer survivors
Breast Cancer Resiliency Through Exercise Program (B-REP): Pilot Study
This study tests whether a personalized 12-week exercise program can help Black breast cancer survivors become more active compared to a health education group.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 75 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University of Michigan Rogel Cancer Center Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Ann Arbor, Michigan) |
| Trial ID | NCT06100263 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a 12-week individualized exercise program for Black breast cancer survivors compared to a health education control. It employs a cross-sectional design with assessments at baseline, after the intervention, and three months post-intervention. The goal is to improve physical activity levels among participants who are not currently meeting exercise guidelines. The study focuses on women who have completed their primary cancer treatments and are within five years of diagnosis.
Who should consider this trial
Good fit: Ideal candidates are Black or Afro-Latina women aged 18 and older who have been diagnosed with Stage I to IIIA breast cancer and completed their primary treatment within the last five years.
Not a fit: Patients with metastatic breast cancer or those unable to increase their exercise levels for medical reasons may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could enhance the physical health and overall well-being of Black breast cancer survivors.
How similar studies have performed: Other studies have shown positive outcomes with exercise interventions for cancer survivors, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Women will be eligible if they meet the following criteria: * self-identify as Black or African American or Afro-Latina/e; * are ≥18 years old; * have a confirmed diagnosis of breast cancer, Stage I to IIIA; * have completed primary active treatment (i.e., surgery, chemotherapy, and radiation) within 5 years prior to study start where concomitant hormonal therapy is acceptable; * are not meeting current cancer-specific resistance exercise guidelines of ≥ 2 times per week; and * are able to speak and understand English. Exclusion Criteria: * metastatic disease; * medical reason that precludes them from increasing current exercise levels; * planned elective surgery during study period; * pregnant or plans to become pregnant during the study period; * plans to move out of United States during the study period; (the rationale for this exclusion is that it will be difficult to conduct the in-person assessments if a participant leaves the United States); * current enrollment in another exercise trial; and/or * inability to pass exercise pre-screening or receive physician consent to increase current physical activity levels.
Where this trial is running
Ann Arbor, Michigan
- University of Michigan — Ann Arbor, Michigan, United States (Recruiting)
Study contacts
- Principal investigator: Angela Fong, PhD — University of Michigan Rogel Cancer Center
- Study coordinator: Cancer AnswerLine
- Email: CancerAnswerLine@med.umich.edu
- Phone: 1-800-865-1125
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.